BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Satapathy SR, Topi G, Osman J, Hellman K, Ek F, Olsson R, Sime W, Mehdawi LM, Sjölander A. Tumour suppressor 15-hydroxyprostaglandin dehydrogenase induces differentiation in colon cancer via GLI1 inhibition. Oncogenesis 2020;9:74. [PMID: 32814764 DOI: 10.1038/s41389-020-00256-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Montaño-Samaniego M, Bravo-Estupiñan DM, Méndez-Guerrero O, Alarcón-Hernández E, Ibáñez-Hernández M. Strategies for Targeting Gene Therapy in Cancer Cells With Tumor-Specific Promoters. Front Oncol 2020;10:605380. [PMID: 33381459 DOI: 10.3389/fonc.2020.605380] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
2 Ghatak S, Mehrabi SF, Mehdawi LM, Satapathy SR, Sjölander A. Identification of a Novel Five-Gene Signature as a Prognostic and Diagnostic Biomarker in Colorectal Cancers. Int J Mol Sci 2022;23:793. [PMID: 35054980 DOI: 10.3390/ijms23020793] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Sun CC, Zhou ZQ, Yang D, Chen ZL, Zhou YY, Wen W, Feng C, Zheng L, Peng XY, Tang CF. Recent advances in studies of 15-PGDH as a key enzyme for the degradation of prostaglandins. Int Immunopharmacol 2021;101:108176. [PMID: 34655851 DOI: 10.1016/j.intimp.2021.108176] [Reference Citation Analysis]
4 Wen H, Li F, Bukhari I, Mi Y, Guo C, Liu B, Zheng P, Liu S, Hsu S. Comprehensive Analysis of Colorectal Cancer Immunity and Identification of Immune-Related Prognostic Targets. Disease Markers 2022;2022:1-13. [DOI: 10.1155/2022/7932655] [Reference Citation Analysis]